Abstract
The present study was conducted on North Indian population to observe rpoB gene mutation profile in multidrug resistant Mycobacterium tuberculosis. This was an observational study. 30 cases of MDR-TB proven by culture and drug sensitivity were selected. DNA sequencing of 81 bp (codon 507–533) long RRDR of Mycobacterium tuberculosis was done to detect the sites of mutation. Out of 30 cases, 24 showed a single mutation in the RRDR region of rpoB gene in which 16 (53.33 %) showed mutation in codon 531(TCG→TTG), 5 cases (16.66 %) showed mutation in codon 526(CAC→TAC), mutation in codon 516(GAC→GTC, AAC) was present in 3 cases (10 %). It was also observed that mutation in more than one codon was present in 4 cases (13.33 %), which included deletion at codon 509(AGC→–GC), mutation at 513(CAA→CTA), 516, 526, 529(CGA→CTA) and 531. No mutation was detected in RRDR in 2 cases (6.66 %). Our finding of 13.33 % cases with multiple sites of mutation in RRDR region is in contrast to earlier studies done in North India which showed single mutation detected in RRDR of rpoB gene that highlights the emerging change in the trend of mutation profile of rpoB gene in rifampicin resistant Mycobacterium tuberculosis.
Similar content being viewed by others
References
Central TB Division, Ministry of Health and Family Welfare. TB India: RNTCP status report 2010. New Delhi, Govt. of India. p. 1.
World Health Organisation. The Global Plan To Stop TB 2011–2015: transforming the fight towards elimination of tuberculosis. WHO/HTM/TB/2008.394. Geneva: World Health Organization; 2010. p. 29.
World Health Organisation. Anti-tuberculosis drug resistance in the world: fourth global report. Geneva: World Health Organization 2008;4:15–20.
World Health Organisation. Global Tuberculosis Control: WHO report 2011. Geneva: World Health Organization; 2011.
Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A. Characterization by Automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol. 1994;4:1095–8.
Ohno H, Koga H, Kohno S, Tashiro T, Hara K. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrobiol Agents Chemother. 1996;40:1053–6.
Hirano K, Abe C, Takahashi M. Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999;37:2663–6.
Deepa P, Therese KL, Madhavan HN. Detection and characterization of mutations in rifampicin resistant Mycobacterium tuberculosis clinical isolates by DNA sequencing. Indian J Tuberc. 2005;52:132–6.
Garcia L, Alonso-Sanz M, Rebollo MJ, Tercero JC, Chaves F. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates in Spain and their rapid detection by PCR-enzyme-linked immunosorbent assay. J Clin Microbiol. 2001;39:1813–8.
Bobadilla-del-valle M, Leon AP, Huertero CA, Alarcon GV, Maeda MK, Small PM, et al. rpoB gene mutations in rifampicin resistant Mycobacterium tuberculosis identified by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP). Emerg Infect Dis. 2001;7:1010–3.
Bostanabad SZ, Noghanian M, Graviss AE, Reza A. Multiple mutations in the rpoB gene of Mycobacterium tuberculosis isolates correlate with high levels of resistance to rifampicin in patients with active pulmonary tuberculosis in Afghanistan border of Iran. Afr J Microbiol Res. 2008;2(4):95–102.
Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB): Policy Statement. Geneva: World Health Organization; 27 June 2008.
Ling DI, et al. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32(5):1165–74.
World Health Organisation. Tuberculosis diagnostics Xpert MTB/RIF test. Fact sheet, WHO; May 2011.
Chakravorty S, Tyagi JS. Novel multipurpose methodology for detection of mycobacteria in pulmonary and extrapulmonary specimens by smear microscopy, culture, and PCR. J Clin Microbiol. 2005;43:2697–702.
Chakravorty S, Dudeja M, Hanif M, Tyagi JS. Utility of universal sample processing methodology, combining smear microscopy, culture, and PCR, for diagnosis of pulmonary tuberculosis. J Clin Microbiol. 2005;43:2703–8.
Ohno H, Koga H, Kuroita T, Tomono K, Ogawa K, Yanagihara K, et al. Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am J Respir Crit Care Med. 1997;155:2057–63.
Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al., editors. Harrison’s, principles of internal medicine: infectious disease: tuberculosis. 17th ed. New York: The McGraw-Hill Companies Inc.; 2008. p. 1006–21.
Sharma SK, Mohan A. Multidrug-resistant tuberculosis. Indian J Med Res. 2004;120:354–76.
Herrera L, Jimenez S, Valverde A, Garci Aranda MA, Saez-Nieto JA. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996–2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents. 2003;21:403–8.
Andreia RM, Lucia M, Rossetti R, Ribeiro MO, Zaha A. Mutations in rpoB gene of multidrug resistant Mycobacterium tuberculosis isolates from Brazil. J Clin Microbiol. 2000;38:3119–22.
Patra SK, Jain A, Sherwal BL, Khanna A. Rapid detection of mutation in RRDR of rpoB gene for rifampicin resistance in MDR-pulmonary tuberculosis by DNA sequencing. Indian J Clin Biochem. 2010;25(3):315–8.
Mercy AL, Lingala L, Aparna S, Jain S, Rao KVSM, Rao PV. Clinical and geographical profiles of rpoB gene mutations in Mycobacterium tuberculosis isolates from Hyderabad and Koraput in India. J Microbiol Antimicrob. 2010;2(2):13–8.
Fan XY, Hu ZY, Xu FH, Yan ZQ, Guo SQ, Li ZM. Rapid detection of rpoB gene mutation in rifampicin resistant Mycobacterium tuberculosis isolates in Sanghai by using the amplification refractory mutation system. J Clin Microbiol. 2003;41:993–7.
World Health Organisation. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis. Policy statement, WHO; 2008.
Acknowledgments
The study was supported by grant from Tapedic Unmolan Samiti, Government of NCT, New Delhi, India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Makadia, J.S., Jain, A., Patra, S.K. et al. Emerging Trend of Mutation Profile of rpoB Gene in MDR Tuberculosis, North India. Ind J Clin Biochem 27, 370–374 (2012). https://doi.org/10.1007/s12291-012-0228-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0228-5